Non-pharmacological interventions for Parkinson’s disease mild cognitive impairment: future directions for research

摘要

Parkinson’sdisease-mildcognitiveimpairment(PD-MCI)currently represents a valid diagnostic clinical entity with potential interest for therapeutic purpose.MCI is present in approximately 25–30%of non-demented patients with PD(Weintraub et al.,2018).Several risk factors are associated with Parkinson’s disease dementia(PDD)occurrence,such asoldageatonset,longdiseaseduration,motorimpairment and MCI(Nicoletti et al.,2019).